Rise Advisors’s GE HealthCare GEHC Stock Holding History

Rise Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-343	Closed	-$25.7K	–	627
2025 Q3	$25.7K	Buy	343 +20	+6%	+$1.49K	0.01%	443
2025 Q2	$23.9K	Hold	323	–	–	0.01%	434
2025 Q1	$26K	Buy	323 +26	+9%	+$2.23K	0.01%	371
2024 Q4	$23.3K	Sell	297 -32	-10%	-$2.72K	0.01%	556
2024 Q3	$30.9K	Sell	329 -13	-4%	-$1.09K	0.01%	398
2024 Q2	$26.7K	Buy	342 +4	+1%	+$326	0.01%	434
2024 Q1	$30.7K	Buy	338 +239	+241%	+$19.9K	0.02%	371
2023 Q4	$7.66K	Sell	99 -10	-9%	-$700	0.01%	344
2023 Q3	$7.42K	Sell	109 -34	-24%	-$2.47K	0.01%	337
2023 Q2	$11.6K	Sell	143 -30	-17%	-$2.39K	0.01%	318
2023 Q1	$14.2K	Buy	+173	New	+$12.4K	0.01%	308

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Rise Advisors's GEHC Position: Q4 2025 in Review

Rise Advisors sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 343 shares — an estimated $25.7K sold.

Rise Advisors first reported a position in GEHC in Q1 2023 and held it in 11 quarters. The position peaked at $30.9K in Q3 2024. 1,338 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

Rise Advisors reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 343 GE HealthCare shares in Q4 2025, an estimated $25.7K.
Rise Advisors first reported a position in GE HealthCare in Q1 2023 and held it in 11 quarters.
Rise Advisors's GE HealthCare position peaked at $30.9K in Q3 2024.
1,338 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.